Claims
| Claim | Type | Assessment | Score | Review checks | References |
|---|---|---|---|---|---|
| In medical-record data, levetiracetam use was linked to longer survival for patients with diffuse midline gliomas but not for patients with hemispheric high-grade gliomas. | COMPARATIVE | Supported | 0.9781 | 1 of 4 | 129 |
| In mice grafted with human diffuse midline gliomas, levetiracetam slowed malignant-cell growth. | OBSERVATIONAL | Supported | 0.9781 | 1 of 4 | 125 |